A change in full-year guidance by management wasn't particularly welcome.

Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. The multiyear effort comes as Merck ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

US pharma giant Merck & Co was trading 4% lower in pre-market Tuesday after the group presented its second quarter 2025 financial results and guidance for the rest of the year.

Merck & Co., Inc. (NYSE: MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A close-up of a person’s hand holding a bottle of pharmaceuticals.

Hyponatremia is low blood sodium, often caused by water retention, diuretics, or illness. Symptoms include nausea and headache. Diagnosis involves assessing volume status and electrolyte levels ...

RAHWAY, N.J., July 22, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend ...

Macsen's current Sodium-Ion battery technology, using its Prussian White as cathode paired with a hard carbon anode, is well suited for applications such as battery energy storage systems (BESS) for ...

Alkali metals are considered as a promising alternative to conventional noble metals for plasmonic applications, offering lower optical loss and significantly reduced material costs. The recent ...

Merck is seeking ways to prepare for a significant upcoming patent cliff. The company has just announced another acquisition that will help it achieve that goal. With its newer products, strong ...

Merck is seeking ways to prepare for a significant upcoming patent cliff. The company has just announced another acquisition that will help it achieve that goal. With its newer products, strong ...